San Diego, California — According to state and local economic development sources TriLink BioTechnologies plans to invest $1,248,806.00 to build out 14,521 square feet of new space in San Diego. The company plans to occupy the new space at 10770 Wateridge Circle in San Diego, on or about March 1, 2021. According to the company website TriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO helping life science leaders and innovators overcome challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA production capabilities, including its proprietary CleanCap mRNA capping technology. TriLink continues to expand its cGMP and general mRNA, oligonucleotide & plasmid manufacturing capacity at its new global headquarters to support therapeutic, vaccine and diagnostic customers.

To learn more about TriLink BioTechnologies, visit http://www.trilinkbiotech.com/

Company Contact:
Brian Neel, Chief Operating Officer
bneel@trilinkbiotech.com
https://www.linkedin.com/in/brianneel/
858-546-0004

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved